Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart study historical cohort

Obesity Facts

Volumn 5, Issue 3, 2012, Pages 319-326

  Cicero, Arrigo F G ^a,d   Magni, Paolo ^b   Moré, Massimo ^c   Ruscica, Massimiliano ^b   Borghi, Claudio ^a   Strollo, Felice ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INRCA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adipokines; Aging; Epidemiology; Metabolic syndrome; Sex hormones

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROSTERONE; DEYDROEPIANDROSTERONE SULPHATE; ESTRONE; GHRELIN; GLUCOSE; LEPTIN; LIPID; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; ITALY; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; DEHYDROEPIANDROSTERONE; ESTRONE; FEMALE; HEALTH SURVEYS; HUMANS; ITALY; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS;

EID: 84862496973     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000339575     Document Type: Article

References (36)

1. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S: Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007; 4(suppl B): S162-177.
2. King GA, Deemer SE, Thompson DL: Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol 2010; DOI: 10.1007/s00592-010-0192-6.
3. Power ML, Schulkin J: Sex differences in fat storage, fat metabolism, and the health risks from obesity: Possible evolutionary origins. Br J Nutr 2008; 99: 931-940.
4. Geer EB, Shen W: Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009; 6(suppl 1):60-75.
5. Israel D, Chua S Jr: Leptin receptor modulation of adiposity and fertility. Trends Endocrinol Metab 2010; 21: 10-16.
6. Dagogo-Jack S, Askari H, Tykodi G, Liu J, Umamaheswaran I: Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women. Horm Res 2008; 70: 174-181.
7. Kong AP, Chan NN, Chan JC: The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome. Curr Diabetes Rev 2006; 2: 397-407.
8. Norata GD, Raselli S, Grigore L, Garlaschelli K, Dozio E, Magni P, Catapano AL: Leptin:adiponectin ratio is an independent predictor of intima-media thickness of the common carotid artery. Stroke 2007; 38: 2844-2846.
9. Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP: Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol 2008; 52: 231-236.
10. Yamamoto Y, Hirose H, Saito I, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein- cholesterol, independent of body mass in the Japanese population. Clin Sci 2002; 103: 137-142.
11. Gavrila A, Chan JL, Yiannakouris N, Heist K, Yiannakouris N, Mantzoros CS: Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration: Cross-sectional and interventional studies. J Clin Endocrinol Metab 2003; 88: 4823-4831.
12. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte derived protein. Diabetes 2002; 51: 2734-2741.
13. Gannage-Yared MG, Khalife S, Semaan M, Fares F, Jambart S, Halaby G: Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 2006; 155: 167-176.
14. Ardawi MS, Rouzi AA: Plasma adiponectin and insulin resistance in women with polycystic ovary disease. Fertil Steril 2005; 83: 1708-1716.
15. Lanfranco F, Zitzmann M, Simoni M, Nieschlag E: Serum adiponectin levels in hypogonadal men: Influence of testosterone replacement therapy. Clin Endocrinol 2004; 60: 500-507.
16. Luukkaa V, Pesonen U, Huhtaniemi I, Lehtonen A, Tilvis R, Tuomilehto J, Koulu M, Huupponen R: Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab 1998; 83: 3243-3246.
17. Buettner R, Bollheimer LC, Zietz B, Lackner K, Schmitz G, Schölmerich J, Palitzsch KD: Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. J Endocrinol 2002; 175: 745-756.
18. Isidori AM, Strollo F, Morè M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A: Leptin and aging: Correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000; 85: 1954-1962.
19. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C: Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661-1667.
20. Caprio M, Fabbrini E, Isodori AM, Aversa A, Fabbri A: Leptin in reproduction. Trends Endocrinol Metab 2001; 12: 65-72.
21. -Cicero AFG, Dormi A, D'Addato S, Borghi C, on behalf of the Brisighella Heart Study Staff: From risk factor assessment to cardiovascular disease risk and mortality modification: The first 40 years of the Brisighella Heart Study. Clin Lipidol 2011; 6: 269-276.
22. Cicero AFG, Dormi A, D'Addato S, Gaddi AV, Borghi C, on behalf of the Brisighella Heart Study Group: Longterm effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: The Brisighella Heart Study. J Women Health 2010; 19: 133-137.
23. Magni P, Ruscica M, Dozio E, Passafaro L, Stefani L, Morelli P, Banfi G, Corsi MM: Plasma adiponectin and leptin concentrations in professional rugby players. J Biol Reg Hom Agents 2010; 24: 87-91.
24. Bertoli S, Magni P, Krogh V, Ruscica M, Dozio E, Testolin G, Battezzati A: Is ghrelin a signal of decreased fat free mass in elderly subjects? Eur J Endocrinol 2006; 155: 321-330.
25. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239.
26. Dullaart RP, Kappelle PJ, Dallinga-Thie GM: Carotid intima-media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. Atherosclerosis 2010; 211: 393-396.
27. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, Xu J, Yang X: Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 2009; 84: 27-33.
28. Milewicz A, Zatonska K, Demissie M, Jêdrzejuk D, Dunajska K, Ilow R, Lwow F: Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gynecol Endocrinol 2005; 20: 68-73.
29. Ibáñez L, López-Bermejo A, del Rio L, Enríquez G, Valls C, de Zegher F: Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 2007; 92: 1710-1714.
30. Perusquía M, Stallone JN: Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol 2010; 298:H1301-1307.
31. Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V, Tchernof A: Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J Endocrinol 2006; 191: 637-649.
32. Dunajska K, Milewicz A, Szymczak J, Jêdrzejuk D, Kuliczkowski W, Salomon P, Nowicki P: Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis. Aging Male 2004; 7: 197-204.
33. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1600.
34. -Samara A, Herbeth B, Aubert R, Berrahmoune H, Fumeron F, Siest G, Visvikis-Siest S: Sex-dependent associations of leptin with metabolic syndrome-related variables: The Stanislas study. Obesity 2010; 18: 196-201.
35. Engberding N, Wenger NK: Cardiovascular disease prevention tailored for women. Expert Rev Cardiovasc Ther 2008; 6: 1123-1134.
36. Labruna G, Pasanisi F, Nardelli C, Caso R, Vitale DF, Contaldo F, Sacchetti L: High leptin/adiponectin ratio and serum triglycerides are associated with an 'at-risk' phenotype in young severely obese patients. Obesity 2011; 19: 1492-1496.